Kaori Morimoto

621 total citations
29 papers, 528 citations indexed

About

Kaori Morimoto is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Kaori Morimoto has authored 29 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Kaori Morimoto's work include Drug Transport and Resistance Mechanisms (10 papers), Influenza Virus Research Studies (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Kaori Morimoto is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Influenza Virus Research Studies (4 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Kaori Morimoto collaborates with scholars based in Japan and Italy. Kaori Morimoto's co-authors include Takuo Ogihara, Saburo Onishi, Isao Nishimori, Tomoko Minakuchi, Daniela Vullo, Andrea Scozzafava, Claudiu T. Supuran, Takashi Kano, Hiroaki Takeuchi and Tomomi Furihata and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Kaori Morimoto

28 papers receiving 519 citations

Peers

Countries citing papers authored by Kaori Morimoto

Since Specialization

Citations

This map shows the geographic impact of Kaori Morimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaori Morimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaori Morimoto more than expected).

Fields of papers citing papers by Kaori Morimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaori Morimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaori Morimoto. The network helps show where Kaori Morimoto may publish in the future.

Co-authorship network of co-authors of Kaori Morimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kaori Morimoto. A scholar is included among the top collaborators of Kaori Morimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaori Morimoto. Kaori Morimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intestinal secretion of indoxyl sulfate as a possible compensatory excretion pathway in chronic kidney disease 2018 ·Biopharmaceutics & Drug Disposition ·Kaori Morimoto, (unknown), (unknown), (unknown), (unknown), A Takahashi, (unknown), Kentarô Yano, Chihaya Kakinuma, Takuo Ogihara, Mikio Tomita	13
2	Interaction of Peptide Transporter 1 With d-Glucose and l-Glutamic Acid; Possible Involvement of Taste Receptors 2016 ·Journal of Pharmaceutical Sciences ·Hiroshi Arakawa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yasuko Hatano, Kentarô Yano, Kaori Morimoto, Takuo Ogihara	6
3	Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir: a case report 2015 ·BMC Neurology ·Kaori Morimoto, (unknown), Akira Nagai, Hirofumi Kashii, Masakiyo Hosokawa, Yukitoshi Takahashi, Takuo Ogihara, Masaya Kubota	13
4	Possible interaction of quinolone antibiotics with peptide transporter 1 in oral absorption of peptide‐mimetic drugs 2015 ·Biopharmaceutics & Drug Disposition ·Hiroshi Arakawa, (unknown), (unknown), Yasuko Hatano, (unknown), Kentarô Yano, Kaori Morimoto, Takuo Ogihara	1
5	Multiple Linear Regression Analysis Indicates Association of P-Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity Measured with a Sensor 2014 ·Journal of Pharmaceutical Sciences ·Kentarô Yano, (unknown), Kaori Morimoto, Tamami Haraguchi, Hiroshi Arakawa, Miyako Yoshida, Fumiyoshi Yamashita, Takahiro Uchida, Takuo Ogihara	4
6	Characterization of Cesium Uptake Mediated by a Potassium Transport System of Bacteria in a Soil Conditioner 2014 ·Biological and Pharmaceutical Bulletin ·(unknown), (unknown), Kentarô Yano, (unknown), (unknown), Hiroshi Arakawa, Kaori Morimoto, Akira Tsuji, Takuo Ogihara	11
7	Role of P-Glycoprotein in Regulating Cilnidipine Distribution to Intact and Ischemic Brain 2013 ·Drug Metabolism and Pharmacokinetics ·Kentarô Yano, (unknown), (unknown), (unknown), (unknown), (unknown), Kaori Morimoto, Akira Takahara, Takuo Ogihara	17
8	Developmental changes of brain distribution and localization of oseltamivir and its active metabolite Ro 64-0802 in rats 2012 ·The Journal of Toxicological Sciences ·Kaori Morimoto, (unknown), Noriko Matsumoto, (unknown), Takashi Kano, Chihaya Kakinuma, Takuo Ogihara	8
9	Pharmacokinetics Parameters in Drug Package Inserts (3) 2011 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), (unknown), Takashi Kano, Yuko Okada, Kaori Morimoto, Yoshimichi Sai, Takuo Ogihara	1
10	Effect of Milk on the Pharmacokinetics of Oseltamivir in Healthy Volunteers 2011 ·Journal of Pharmaceutical Sciences ·Kaori Morimoto, (unknown), (unknown), (unknown), Yoichiro Ogama, (unknown), (unknown), (unknown), (unknown), Akihiro Inano, Takashi Kano, Ikumi Tamai, Takuo Ogihara	27
11	Effect of Knockdown of Ezrin, Radixin, and Moesin on P-Glycoprotein Function in HepG2 Cells 2011 ·Journal of Pharmaceutical Sciences ·Takashi Kano, (unknown), Kaori Morimoto, Yukio Kato, Takuo Ogihara	44
12	Enhancement of Drug Solubility and Absorption by Copolymers of 2-Methacryloyloxyethyl Phosphorylcholine and n-Butyl Methacrylate 2010 ·Drug Metabolism and Pharmacokinetics ·Takashi Kano, Chihaya Kakinuma, (unknown), Kaori Morimoto, Takuo Ogihara	12
13	Oseltamivir (Tamiflu) Is a Substrate of Peptide Transporter 1 2009 ·Drug Metabolism and Disposition ·Takuo Ogihara, Takashi Kano, (unknown), (unknown), Hikaru Yabuuchi, (unknown), Kaori Morimoto, Yoshiyuki Shirasaka, Shoko Kobayashi, Ikumi Tamai	43
14	Involvement of Hepatocyte Nuclear Factor 4alpha in Transcriptional Regulation of the Human Pregnane X Receptor Gene in the Human Liver 2008 ·Drug Metabolism and Pharmacokinetics ·(unknown), Kaoru Kobayashi, Kaori Morimoto, (unknown), (unknown), Tomomi Furihata, Kan Chiba	21
15	Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha are Factors Involved in Interindividual Variability in the Expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in Human Livers††This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan (Health and Labor Sciences Research Grants, Research on Human genome, Tissue Engineering; Health and Labor Sciences Research Grants, Risk Analysis Research on Food and Pharmaceuticals), and was partially supported by grants (18890044 and 17790112) from the Ministry of Education, Sciences, Sports and Culture of Japan. 2007 ·Drug Metabolism and Pharmacokinetics ·Sasitorn Aueviriyavit, Tomomi Furihata, Kaori Morimoto, Kaoru Kobayashi, Kan Chiba	32
16	Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori 2006 ·Bioorganic & Medicinal Chemistry Letters ·Isao Nishimori, Daniela Vullo, Tomoko Minakuchi, Kaori Morimoto, Saburo Onishi, Andrea Scozzafava, Claudiu T. Supuran	33
17	Carbonic Anhydrase Inhibitors: DNA Cloning and Inhibition Studies of the α-Carbonic Anhydrase from Helicobacter pylori, A New Target for Developing Sulfonamide and Sulfamate Gastric Drugs 2006 ·Journal of Medicinal Chemistry ·Isao Nishimori, Tomoko Minakuchi, Kaori Morimoto, (unknown), Saburo Onishi, Hiroaki Takeuchi, Daniela Vullo, Andrea Scozzafava, Claudiu T. Supuran	142
18	OATP-C(OATP01B1)15 is associated with statin-induced myopathy in hypercholesterolemic patients 2005 ·Clinical Pharmacology & Therapeutics* ·Kaori Morimoto, Shiro Ueda, Naohiko Seki, (unknown), Yukiyoshi Kameyama, (unknown), (unknown), Masakiyo Hosokawa, K Iesato, Seijiro Mori	23
19	Expression of carbonic anhydrase-related protein VIII, X and XI in the enteric autonomic nervous system 2003 ·Biomedical Research-tokyo ·Isao Nishimori, Tamotsu Takeuchi, Kaori Morimoto, Keisuke Taniuchi, Nobuto Okamoto, Saburo Onishi, Yuji Ohtsuki	5
20	Molecular cloning and sequence of cDNAs for the import precursors of oligomycin sensitivity conferring protein, ATPase inhibitor protein, and subunit c of H+-ATP synthase in rat mitochondria 1993 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Tomihiko Higuti, (unknown), (unknown), Kaori Morimoto, (unknown)	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact